Psychometric Assessment of the Injection Pen Assessment Questionnaire (IPAQ): measuring ease of use and preference with injection pens for human growth hormone
Open Access
- 1 January 2012
- journal article
- research article
- Published by Springer Nature in Health and Quality of Life Outcomes
- Vol. 10 (1) , 126
Abstract
To examine the psychometric properties of the Injection Pen Assessment Questionnaire (IPAQ) including the following: 1) item and scale characteristics (e.g., frequencies, item distributions, and factor structure), 2) reliability, and 3) validity. Focus groups and one-on-one dyad interviews guided the development of the IPAQ. The IPAQ was subsequently tested in 136 parent-child dyads in a Phase 3, 2-month, open-label, multicenter trial for a new Genotropin(®) disposable pen. Factor analysis was performed to inform the development of a scoring algorithm, and reliability and validity of the IPAQ were evaluated using the data from this two months study. Psychometric analyses were conducted separately for each injection pen. Confirmatory factor analysis provides evidence supporting a second order factor solution for four subscales and a total IPAQ score. These factor analysis results support the conceptual framework developed from previous qualitative research in patient dyads using the reusable pen. However, the IPAQ subscales did not consistently meet acceptable internal consistency reliability for some group level comparisons. Cronbach's alphas for the total IPAQ score for both pens were 0.85, exceeding acceptable levels of reliability for group comparisons. The total IPAQ score is a useful measure for evaluating ease of use and preference for injection pens in clinical trials among patient dyads receiving hGH. The psychometric properties of the individual subscales, mainly the lower internal consistency reliability of some of the subscales and the predictive validity findings, do not support the use of subscale scores alone as a primary endpoint.Keywords
This publication has 18 references indexed in Scilit:
- Treatment adherence with the easypod™ growth hormone electronic auto-injector and patient acceptance: survey results from 824 children and their parentsBMC Endocrine Disorders, 2011
- Ease of use and preference for a new disposable self-injection pen compared with a reusable pen for administering recombinant human growth hormone: A multicenter, 2-Month, single-arm, open-label clinical trial in patient-caregiver dyadsClinical Therapeutics, 2010
- Patient acceptance of a novel electronic auto-injector device to administer recombinant human growth hormone: results from an open-label, user survey of everyday useCurrent Medical Research and Opinion, 2007
- Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidanceHealth and Quality of Life Outcomes, 2006
- A qualitative analysis of a dyad approach to health-related quality of life measurement in children with asthmaSocial Science & Medicine, 2006
- Health of children with chronic arthritis: Relationship of different measures and the quality of parent proxy reportingArthritis Care & Research, 2004
- Agreement between adolescent self‐report and parent reports of health and well‐being: results of an epidemiological studyChild: Care, Health and Development, 2003
- The PedsQL™ in pediatric rheumatology: Reliability, validity, and responsiveness of the Pediatric Quality of Life Inventory™ generic core scales and rheumatology moduleArthritis & Rheumatism, 2002
- Recommendations for Evaluating the Validity of Quality of Life Claims for Labeling and PromotionValue in Health, 1999
- Health-related quality of life in childhood cancer: Discrepancy in parent-child reportsInternational Journal of Cancer, 1999